Right click to download
New data insights reveal that 38% of US Biotechnology, Life Science and Pharmaceutical companies mentioned Clinical Trials with high emphasis in their reports, against 13% of EU companies.
Interestingly, Disease Awareness and Education is discussed more in Europe than North America.
As a trusted partner of the established consulting firms and multinationals, Datamaran helps with benchmarking, materiality and risk analysis.
Datamaran’s proprietary software enables data-driven decision-making by analyzing publicly available sources, such as; corporate reports, regulations, news and social media. The company captures evidence-based insights for more than 7,000 companies and tracks all regulatory initiatives worldwide.
Get your complimentary demo of Datamaran to find out how you can improve and streamline your materiality analysis process.